GPC
32
-5
DNB
38
-4
AEP
35
-10
ITW
53
-2
CB
46
-2
AMG
41
-2
WMT
71
3
BXP
46
-9
EXPE
51
-2
XRX
50
-2
MPC
49
-3
SEE
34
-2
SYK
55
7
ADT
35
-2
WEC
29
-12
K
33
-2
COST
63
2
FAST
48
2
ILMN
42
5
EMC
100
3
GPC
32
-5
DNB
38
-4
AEP
35
-10
ITW
53
-2
CB
46
-2
AMG
41
-2
WMT
71
3
BXP
46
-9
EXPE
51
-2
XRX
50
-2
MPC
49
-3
SEE
34
-2
SYK
55
7
ADT
35
-2
WEC
29
-12
K
33
-2
COST
63
2
FAST
48
2
ILMN
42
5
EMC
100
3
Financhill
Back

Arcutis Biotherapeutics Vs. Marinus Pharmaceuticals Industry Stock Comparison

Buy
62

ARQT
Arcutis Biotherapeutics

Last Price:
10.49
Seasonality Move:
-17.15%
Sell
28

MRNS
Marinus Pharmaceuticals

Last Price:
1.21
Seasonality Move:
31.2%
Buy
62
Arcutis Biotherapeutics (ARQT) is a Buy

Is Arcutis Biotherapeutics a Buy, Sell or Hold?

  • The current Arcutis Biotherapeutics [ARQT] share price is $10.49. The Score for ARQT is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • ARQT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
28
Marinus Pharmaceuticals (MRNS) is a Sell

Is Marinus Pharmaceuticals a Buy, Sell or Hold?

  • The current Marinus Pharmaceuticals [MRNS] share price is $1.20. The Score for MRNS is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • MRNS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ARQT Stock Price Chart

What is Arcutis Biotherapeutics's stock price today?

  • The Arcutis Biotherapeutics share price today is $10.49
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARQT is experiencing buying pressure, which is a positive indicator for future bullish movement.

MRNS Stock Price Chart

What is Marinus Pharmaceuticals's stock price today?

  • The Marinus Pharmaceuticals share price today is $1.20
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MRNS is experiencing slight selling pressure.

ARQT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.34 Buy
Relative Strength Index (14 RSI): 65.81 Buy
Chaikin Money Flow: 2760653 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.82 - 9.42) Buy
Bollinger Bands (100): (8.13 - 10.53) Buy

MRNS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.15 Sell
Relative Strength Index (14 RSI): 32.98 Sell
Chaikin Money Flow: -51634 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.27 - 1.51) Sell
Bollinger Bands (100): (0.86 - 8.58) Sell

ARQT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.57 Buy
20-day SMA: 8.73 Buy
50-day SMA: 8.63 Buy
200-day SMA: 6.43 Buy
8-day EMA: 9.54 Buy
20-day EMA: 9.07 Buy
50-day EMA: 8.87 Buy
200-day EMA: 8.27 Buy

MRNS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.24 Sell
20-day SMA: 1.37 Sell
50-day SMA: 1.39 Sell
200-day SMA: 6.47 Sell
8-day EMA: 1.24 Sell
20-day EMA: 1.34 Sell
50-day EMA: 2.14 Sell
200-day EMA: 5.44 Sell

Arcutis Biotherapeutics Earnings Growth & ARQT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.25 per share, and an increase next year of $0.48 per share.

Marinus Pharmaceuticals Earnings Growth & MRNS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, an increase next quarter of $0.24 per share, an increase this year of $0.58 per share, and an increase next year of $0.88 per share.

Arcutis Biotherapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Marinus Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):